Lam Kwing Tong

All filings by Lam Kwing Tong on record concern Jacobson Pharma Corporation Ltd. We count 5 filings; the first trade dates from 17 January 2018 and the latest from 28 January 2021.

The open-market side counts 4 purchases for €35k alongside 1 sale. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2021 to date brings 1 purchase and no sales.

The median purchase comes to €7,471. Clusters matter here: 2 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 25% of cases, with a median move of +0.0%. These figures describe past trades and do not predict future prices.

Most recently, on 29 January 2021, the filings show an open-market purchase worth €15k in Jacobson Pharma Corporation Ltd. Between a trade and the moment it shows up on HKEX, the median delay is 1 day. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.